Skip to main content

HomeResearchPTD-DBM

CategorySkin & Joint
SafetyLow Risk
StatusResearch Only

PTD-DBM

Wnt signaling activating peptide · PDGFR transmembrane-DBM · hair follicle Wnt peptide

CategorySkin & Joint
Half-life
Routetopical, intradermal
RiskLow Risk
Providers6 listed

About PTD-DBM

Contains a protein transduction domain enabling intracellular delivery. Disrupts Dishevelled-Axin protein interaction, preventing β-catenin degradation and activating Wnt target genes essential for hair follicle cycling and new follicle neogenesis.

A cell-penetrating peptide that activates Wnt/β-catenin signaling in hair follicle dermal papilla cells. Studied as a potential hair regeneration therapy acting through a mechanism distinct from minoxidil and finasteride.

Research Areas

hair regenerationhair follicle activationWnt pathway modulationfollicle neogenesis

Regulatory & Evidence

Risk Profile

Low Risk

Generally considered lower risk in research contexts. Risk profile varies by individual — review contraindications before use.

Regulatory Status

Availability Status
Research Only

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Safety Notes

Low Risk

Generally considered lower risk in research contexts. Individual response varies — review all considerations before use.

Reported contraindications & considerations

Active Cancer HistoryPregnant Or Nursing

Consult a qualified healthcare professional before making any health decisions. This information is educational only and does not constitute medical advice.

Where to Find PTD-DBM

6 providers

Frequently Asked Questions — PTD-DBM

A cell-penetrating peptide that activates Wnt/β-catenin signaling in hair follicle dermal papilla cells. Studied as a potential hair regeneration therapy acting through a mechanism distinct from minoxidil and finasteride.

hair regeneration, hair follicle activation, Wnt pathway modulation, follicle neogenesis.

6 providers in the directory currently offer PTD-DBM.

Newsletter

The Peptide Research Digest

New providers, emerging stacks, and research developments — weekly.

No spam. Unsubscribe anytime. Privacy policy.